ArticleJournal of clinical medicine2020

Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial.

Pei-Hsun Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.